期刊文献+

慢性心力衰竭合并贫血的临床研究进展 被引量:2

暂未订购
导出
摘要 慢性心力衰竭(CHF)已经成为全球关注的公共卫生问题,近年来,随着血管转化酶抑制剂及8受体阻滞剂的规范应用及心脏再同步化治疗(CRT)盼广泛推广,患者的临床症状及生活质量已明显得到改善,心衰的死亡率下降8%,但CHF的远期治疗效果仍欠佳。近年来,CHF与贫血的关系逐渐得到重视,二者在疾病的进展过程中互为因果,提高了治疗难度。心衰常合并肾功能障碍,如与贫血同时存在时对CHF的的死亡风险会产生叠加作用。本文就CHF与贫血、肾功能不全的定义、发病机制、及治疗进展做了简略介绍。
作者 王玉玲 郑杨
出处 《吉林医学》 CAS 2011年第4期757-758,共2页 Jilin Medical Journal
  • 相关文献

参考文献11

  • 1Mitchell JE.Emergine role of anemia in heart failure[J].Am J Cardiol,2007,99(6B):15D.
  • 2Kirkwood F.Adams,John H.Patterson,Pharm D,et al.Prospective ass essment of the occurrence of anemia in patients with heart failure:Results from the Study of Anemia in a Heart Failure Population[J].Am Heart J,2009,157(9):926.
  • 3Amir Kazory,Edward A.Ross.Anemia:The Point of Convergence or Divergence for Kidney Disease and Heart Failure? Gainesville,Florida[J].J Am Coll Cardiol,2009,53(8):639.
  • 4Michael G,Felker MD,Linda K,et al.Anemia in patients with heart failure and preserved systolic function[J].Am Heart J,2006,151(5):457.
  • 5Justin A.Ezekowitz,MBBCh,Finlay A.McAlister,et al.Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes,Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure[J].Circulation,2003,107(3):223.
  • 6lshani A,Weinhandl E,Zhao Z,et al.Angiotansin-conver-ting enzyme inhibitor as a risk factor for the development of anemia,and the impact of incident anemia on mortality in patients with left ventricular dysfunction[J].J Am Coll Cardiol,2005,45(3):391.
  • 7Opaich C,Cazzola M,Scelsi L,et al.Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure[J].Eur Heart J,2005,26(21):2232.
  • 8郗爱旗,褚以德,钟欣,李英兰,廖宝霞,尚玲,李国峰,赵文蕊.慢性心力衰竭患者贫血与肾功能和神经内分泌细胞因子的关系[J].中华老年心脑血管病杂志,2008,10(1):24-26. 被引量:7
  • 9Silverberg DS,Wexier D,Iaina A,et al.Amenia,chronic renal disease and congestive heart failure,the cardiorenal anemia synddrome:the need for cooperation between cardiologists and nephrologists[J].Int Urol Nephrol,2003,38(3):295.
  • 10Alberto Palazzuoli,Donald Silverberg.Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia[J].Am Heart J,2006,152(11):1096.

二级参考文献8

  • 1Caiola K,Cheng JW.Use of erythropoietin in heart failure management[J].Ann Pharmacother,2004,38(12):2145-2149.
  • 2Silverberg DS,Wexler D,Shep SD,et al.The effect of connection of mild anemia in severe,resistant congestive heart failure using subcutaneous Erythropoietin and intravenous iron:a randomized controlled study[J].J Am Coll Cardiol,2001,37(7):1775-1780.
  • 3van derMeer P,Voors AA,Lipsie E,et al.Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure[J].J Am coll Cardiol,2004,44(1):63-67.
  • 4Silverberg DS, Wexler D, Iaina A, et al. Anemia, chronic renal disease and congestive heart failure the cardiorenal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol, 2006,38 : 295- 310.
  • 5Inder MD,John JV,McMurray MD,et al. Anemia and its relationship to clinical outcome in heart failure. Circulation, 2004, 110:149 -151.
  • 6Dominguez A,Pena J. perez M, et al. Long-term prognosis value of anemia in a non selected population with heart failure. Med Clin,2007,128:370- 371.
  • 7Silverberg DS, Wexler D, Iaina A, et al. The interaction between heart failure and other heart diseases, renal failure,and anemia. Semin Nephrol, 2006,26 . 296-306.
  • 8Manolis AS, Tzeis S, Triataafyllou K, et al. Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotroplc effects. Curr Drug Targets Cardiovasc Haematol Disord,2005,10:355-375.

共引文献14

同被引文献27

  • 1郭玲,王爱红,吕琳,鹿克风,孙永乐.EPO辅助治疗慢性心力衰竭合并贫血52例临床观察[J].山东医药,2007,47(5):57-58. 被引量:10
  • 2Caiola K, Cheng JW. Use of erythropoietin in heart failure management [ J ]. The Annals of Pharmacotherapy, 2004,38 (12) :2145 - 2149.
  • 3Anand I, McMurray JJV, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure [J ]. Cir- culation,2004,110(2) : 149 - 154.
  • 4Mitchell JE. Emergine role of anemia in heart failure [ J ]. Am J Cardiol,2007,99(6B) :15D.
  • 5Silverberg DS, Wexler D, Laina A. The importance of ane- mia and its correction in the management of severe congestive heart failure [J]. Eur J Hear Fail,2002,4:681 - 686.
  • 6Kirkwood F, Adams. Prospective ass essment of the occur- rence of anemia in patients with heart failure: Results from the study of anemia in a heart failure population [ J ]. Am Heart J,2009,157(9) :926.
  • 7Opaich C, Cazzola M, Scelsi L, et al. Blunted erythropoi- etin production and defective iron supply for erythropoiesis ah major causes of anemia in patiens with chronic heart failure [J]. Eur Heart J ,2005,26(21) :2232.
  • 8Horl WH. Iron therapy for renal anemia:how much need- ed ,how much harmful? [ J ]. Pediatr Nephrol, 2007,224 : 480 - 489.
  • 9Balla J, Jeney V, Varga ZS, et al. Iron homeostasis in chronic irr[lammation [J]. Acta Physiol Hung, 2007,94 ( 1 - 2) :95 - 106.
  • 10Van der Putten K, Braam B, Jie KE, et al. Mechanisms of Disaese: erythropoietin resistance in patients with both heart and kidney failure [J]. Nat Clin Pratt Nephrol, 2008, 4(1):47 -57.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部